Research Has Found a Diabetes Drug and Pancreatic Cancer Association

According to a study, 2 drugs made use of for treating type 2 diabetes may be associated with a significantly higher risk of the development of pancreatic cancer and pancreatitis, and 1 of the drugs may be associated with an increased thyroid cancer risk. Researchers analyzed the FDA’s database for adverse events reported by individuals making use of the type 2 diabetes drugs exenatide and sitagliptin.[1] A 6 times the increase in the odds ratio for reported pancreatitis cases with these drugs was found, in comparison to 4 other diabetes control therapies. It was also found that individuals using the two type 2 diabetes drugs were more likely to have had pancreatic cancer compared to those who were given the other therapies.

Exenatide and sitagliptin are type 2 diabetes drugs which improve the actions of a gut hormone called GLP-1 (glucagon-like peptide 1), which is effective for the lowering of blood sugar in type 2 diabetes patients. Sitagliptin, sold as Januvia, works by inhibiting DDP-4 (dipeptidyl peptidase-4), an enzyme which degrades GLP-1. Exenatide, marketed as Byetta, imitates the GLP-1 action and resists degradation of DDP-4.

Earlier research suggested there could be a connection between drugs which enhance the actions of GLP-1 and pancreatitis, possibly caused by an increase in the rate of formation pancreatic duct cells.

As well as six times the increase in reported cases of pancreatitis, a 2.7 times higher rate of pancreatic cancer in individuals on sitagliptin was also found and a 2.9 times greater rate of pancreatic cancer in individuals making use of exenatide, in comparison to the other therapies. A statistically significant increase in the risk of thyroid cancer among the exenatide group was also found, but not in the sitagliptin group.

The researchers cautioned that the adverse events database from the FDA isn’t the ideal solution for comparing adverse event rates in type 2 diabetes drugs, due to its known limitations, like reporting biases and incomplete data. However, both the American Diabetes Association and the American Medical Association advise that the link between Januvia and pancreatic cancer is prevalent.

Sale
CuraLife Dietary Supplement, CuraLin Blood Sugar Support Supplement,...
680 Reviews
CuraLife Dietary Supplement, CuraLin Blood Sugar Support Supplement,...
  • A Healthy & Balanced Lifestyle: CuraLin natural capsules reduce the craving for sweets & carbs and promotes high daily energy levels;...
  • The Power of Science: CuraLin works powerfully by blending ancient Ayurvedic practices with modern technology to create a one-of-a-kind...
  • Herbal Dietary Supplement: Made with natural ingredients, Bitter Melon, Gymnema Sylvestre, Swertia Chirata, Fenugreek, Syzygium Cumini,...
  • How To Use: Take 1-2 capsules 30 minutes after each meal to enjoy the benefits that CuraLin offers; We believe in the power of nature;

Understanding Pancreatic Cancer Chart

Understanding Pancreatic Cancer
  • Anatomical Chart Company (Author)
  • English (Publication Language)
  • 1 Page - 06/15/2010 (Publication Date) - Anatomical Chart Co (Publisher)

Want to use our images on your site? Right click on image for embed code

[mailerlite_form form_id=1]
close

Simply copy and paste the code below to embed the image on your page